University of Michigan, and the Albert Einstein Medical Center 
of Yeshiva University. 
20. On October 7, 1974 the Secretary of Health, Education, 
and Welfare under authority of the Federal Advisory Committee Act, 
5 U.S.C. App. I, and the Public Health Service Act, 42 U.S.C. 
6217a, chartered the Recombinant DMA Molecule Program Advisory 
Committee for the purpose of advising the Secretary of the 
Department of Hoalth, Education, and Welfare, the Assistant 
Secretary for Health of the Department of Health, Education, and 
Welfare, the Director of HIH with respect to recombinant DNA 
research. On September 24, 1976 this Advisory Committee was 
renev/ed by the Secretary of the Department of Health, Education, 
and Welfare until June 30, 197&. 
21. On June 23, 1976, the Director of NIH, with the 
approval of the Secretary of the Department of Health, Education, 
and Welfare (DREW), and the Assistant Secretary for Health of the 
DHEW, promulgated guidelines for the conduct of recombinant DNA 
research being done by NIH grantees and by NIH personnel, 
entitled "Recombinant DNA Research Guidelines." 
22. In or about June, 1976, the "Office of Recombinant DNA 
Activities" (OP.DA) was established by the NIH. CRDA is 
responsible for keeping the Office of the Director of NIH 
informed of activities, research, and developments in the 
field of recombinant DNA research, and it is involved in all 
major planning activities leading to the formation of NIH 
policies and procedures with respect to recombinant DNA research. 
23. On August 26, 1976, the Director of NIH issued a 
Draft Environmental Impact Statement (EIS) for the Recombinant 
DNA Research Guidelines. This Draft EIS was published in the 
Federal Register on September 9, 1976, 41 Fed. Reg. 3^26. 
D. REQUIREMENTS OF THE NATIONAL ENVIRONMENTAL POLICY ACT. 
24* On January 1, 1970, the President of the United States 
9 
[B- 113 
